Back to BlackRock, Inc.

ELVN
6 quarters

Position history for BlackRock, Inc.'s holdings in ENLIVEN THERAPEUTICS INC

BlackRock, Inc. holds 3.7M shares of ELVN (ENLIVEN THERAPEUTICS INC), worth $144.4M as of 2026-Q1. The position was increased (+2.0% shares). ELVN represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$144.4M

Current Shares

3.7M

Total Value Change

+$77.7M

Total Shares Change

+719,579

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
3.7M
+2.0%
$144.4M0.0%$28.75
31
2025-Q4
Increased
3.6M
+2.7%
$55.6M0.0%$15.55
30
2025-Q3
Increased
3.5M
+18.6%
$72M0.0%$20.30
35
2025-Q2
Decreased
3M
-1.0%
$59.5M0.0%$20.68
0
2025-Q1
Increased
3M
+1.1%
$59M0.0%$21.07
30
2024-Q4
New
3M
-
$66.7M0.0%$22.39
41

Other major holders of ELVN: FMR LLC, Polar Capital Holdings Plc

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used